BioPharma
Pharmaceutical Contract Sales Market to Hit $26.24B by 2034
Contract Sales Organizations: Transforming Pharma Companies
Contract sales organizations – CSOs are becoming vital tools for pharmaceutical companies to boost sales performance while keeping marketing costs low. These organizations happen to offer experts who work alongside pharmaceutical companies in order...
BioPharma
Asia-Pacific Governments Boost Healthcare Innovation And R&D
Several Asian-Pacific local governments have passed helpful policies and rules in the last five years to improve healthcare and speed up drug research in their own markets. These projects have made it much easier for people in the business...
BioPharma
Biotech Outsourcing: Trends, CDMO Growth, And Expansion
The field of biotechnology has seen tremendous evolution over the past ten years—driven by scientific advances, increasing investment, and an ever-globalized approach to innovation. And during this whole process, the outsourcing of important functions has become a key strategy for the...
BioPharma
Advancing Continuous Bioprocessing For Enhanced Productivity
The biopharmaceutical sector is now going through a significant transition toward continuous bioprocessing which is currently taking place. In contrast to the conventional batch processing method, which is characterized by the presence of distinct phases and interim holding tanks,...
BioPharma
Generative AI In Pharma: Major Opportunities And Hurdles
Among the pharmaceutical DX-digital transformation professionals, 67% responded that they were not ready when asked about how ready the life sciences sector is to effectively go ahead and leverage generative AI in terms of infrastructure, regulatory considerations, and expertise....
BioPharma
Global Biopharma Market To Hit $566B By 2032 Amid Challenges
The value of the global biopharmaceutical industry is expected to rise significantly, from $263 billion in 2022 to $566 billion by 2032, representing a compound annual growth rate of about 8% from 2023 to 2032.
This growth is mostly being...
BioPharma
Thermo Fisher Partners with X-ELIO for Renewable Energy
Thermo Fisher Scientific has taken a significant step toward achieving its sustainability goals by signing a 10-year virtual power purchase agreement (VPPA) with renewable energy developer X-ELIO. This agreement supports the Lorca solar project, which is set to become...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.